A Mechanistic Review on Toxicity Effects of Methamphetamine

Persistent methamphetamine use causes many toxic effects in various organs, including the brain, heart, liver, kidney and eyes. The extent of its toxicity depends on numerous pharmacological factors, including route of administration, dose, genetic polymorphism related to drug metabolism and polysub...

Full description

Bibliographic Details
Published in:International Journal of Medical Sciences
Main Author: Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S.
Format: Review
Language:English
Published: Ivyspring International Publisher 2025
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215677556&doi=10.7150%2fijms.99159&partnerID=40&md5=0c2d3074d5915b4bdc93aef8c7a364d1
id 2-s2.0-85215677556
spelling 2-s2.0-85215677556
Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S.
A Mechanistic Review on Toxicity Effects of Methamphetamine
2025
International Journal of Medical Sciences
22
3
10.7150/ijms.99159
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215677556&doi=10.7150%2fijms.99159&partnerID=40&md5=0c2d3074d5915b4bdc93aef8c7a364d1
Persistent methamphetamine use causes many toxic effects in various organs, including the brain, heart, liver, kidney and eyes. The extent of its toxicity depends on numerous pharmacological factors, including route of administration, dose, genetic polymorphism related to drug metabolism and polysubstance abuse. Several molecular pathways have been proposed to activate oxidative stress, inflammation and apoptosis: B-cell lymphoma protein 2 (Bcl-2)-associated X (Bax)/Bcl2/caspase-3, nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase-1 (HO-1), protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70S6K, trace amine-associated receptor 1 (TAAR1)/cAMP/lysyl oxidase, Sigmar1/ cAMP response element-binding protein (CREB)/mitochondrial fission-1 protein (Fis1), NADPH-Oxidase-2 (NOX-2), renal autophagy pathway, vascular endothelial growth factor (VEGF)/phosphatidylinositol-3-kinase (PI3K)/ protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS), Nupr1/Chop/P53/PUMA/Beclin1 and Toll-like receptor (TLR)4/MyD88/TRAF6 pathways. The activation promotes pathological changes, including the disruption of the blood-brain barrier, myocardial infarction, cardiomyopathy, acute liver failure, acute kidney injury, chronic kidney disease, keratitis, retinopathy and vision loss. This review revisits the pharmacological profiles of methamphetamine and its effects on the brain, heart, liver, eyes, kidneys and endothelium. Understanding the mechanisms of methamphetamine toxicity is essential in developing treatment strategies to reverse or attenuate the progress of methamphetamine-associated organ damage. © The author(s).
Ivyspring International Publisher
14491907
English
Review
All Open Access; Gold Open Access
author Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S.
spellingShingle Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S.
A Mechanistic Review on Toxicity Effects of Methamphetamine
author_facet Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S.
author_sort Ramli F.F.; Rejeki P.S.; ‘Izzah Ibrahim N.; Abdullayeva G.; Halim S.
title A Mechanistic Review on Toxicity Effects of Methamphetamine
title_short A Mechanistic Review on Toxicity Effects of Methamphetamine
title_full A Mechanistic Review on Toxicity Effects of Methamphetamine
title_fullStr A Mechanistic Review on Toxicity Effects of Methamphetamine
title_full_unstemmed A Mechanistic Review on Toxicity Effects of Methamphetamine
title_sort A Mechanistic Review on Toxicity Effects of Methamphetamine
publishDate 2025
container_title International Journal of Medical Sciences
container_volume 22
container_issue 3
doi_str_mv 10.7150/ijms.99159
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215677556&doi=10.7150%2fijms.99159&partnerID=40&md5=0c2d3074d5915b4bdc93aef8c7a364d1
description Persistent methamphetamine use causes many toxic effects in various organs, including the brain, heart, liver, kidney and eyes. The extent of its toxicity depends on numerous pharmacological factors, including route of administration, dose, genetic polymorphism related to drug metabolism and polysubstance abuse. Several molecular pathways have been proposed to activate oxidative stress, inflammation and apoptosis: B-cell lymphoma protein 2 (Bcl-2)-associated X (Bax)/Bcl2/caspase-3, nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase-1 (HO-1), protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70S6K, trace amine-associated receptor 1 (TAAR1)/cAMP/lysyl oxidase, Sigmar1/ cAMP response element-binding protein (CREB)/mitochondrial fission-1 protein (Fis1), NADPH-Oxidase-2 (NOX-2), renal autophagy pathway, vascular endothelial growth factor (VEGF)/phosphatidylinositol-3-kinase (PI3K)/ protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS), Nupr1/Chop/P53/PUMA/Beclin1 and Toll-like receptor (TLR)4/MyD88/TRAF6 pathways. The activation promotes pathological changes, including the disruption of the blood-brain barrier, myocardial infarction, cardiomyopathy, acute liver failure, acute kidney injury, chronic kidney disease, keratitis, retinopathy and vision loss. This review revisits the pharmacological profiles of methamphetamine and its effects on the brain, heart, liver, eyes, kidneys and endothelium. Understanding the mechanisms of methamphetamine toxicity is essential in developing treatment strategies to reverse or attenuate the progress of methamphetamine-associated organ damage. © The author(s).
publisher Ivyspring International Publisher
issn 14491907
language English
format Review
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1823296151919525888